Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the big money stories and how they affect you in our final Mad about Money of the year.

Series: ,
2 top fund managers rate Appen, Xero, Nuix & Zip: To Buy or Not to Buy?!

On this week's show, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard join Peter Switzer.

Series: ,
Should you take a multivitamin every day?

Dr Ross Walker discusses the longest-running trial in relation to multivitamins and the potential benefits of long-term multivitamin use.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money news and how it affects you.

Series: ,
Bevan Slattery explains Megaport & Is Treasury Wine Estates in the buying zone?

In this week's show, Peter Switzer speaks to Adam Dawes, Bevan Slattery, Julia Lee, Paul Rickard, Ying Yi Ann Cheng and Michael Gable.

Series: ,
Do multivitamins work?

Dr Ross Walker points out some issues with recent studies that have suggested multivitamins do nothing.

Series: ,
Could the bad bully boys of Beijing hurt our stock market + Paul’s got 2 stocks to sell & 2 to buy!

Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.

Series: ,
Have the Beijing bad boys turned Treasury Wine Estates and a2 milk into screaming buys?!

On this week's investing show, Peter Switzer is joined by Julia Lee from Burman Invest, Rudi Filapek-VanDyck from FNArena, Jun Bei Liu from Tribeca Investment Partners and Paul Rickard.

Series: ,
New COVID-19 evidence

Dr Ross Walker talks about new evidence of the coronavirus, its fatality rates and possible mutations.

Series: ,
Is ScoMo starting to suck up to the Beijing bad boys & what 2 stocks could benefit?

Join Peter Switzer and Paul Rickard for the latest episode of Mad about Money.

Series: ,
Why is Mesoblast blasting higher again & 3 new stocks that are hot!

On this week's show, Peter Switzer speaks to Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, AMP Capital's Shane Oliver, Switzer's Paul Rickard and nabtrade's Gemma Dale.

Series: ,
The Oxford COVID-19 vaccine trial

Dr Ross Walker looks at the differences between the Oxford and Pfizer vaccine trials and shares the promising results from both.

Series: ,
1 37 38 39 40 41 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram